ワクチンアジュバントのアメリカ市場2018-2023

LP Informationが発行した調査報告書(LPI8051340)
◆英語タイトル:2018-2023 United States Vaccine Adjuvants Market Report (Status and Outlook)
◆商品コード:LPI8051340
◆発行会社(リサーチ会社):LP Information
◆発行日:2018年2月5日
◆ページ数:87
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single UserUSD3,360 ⇒換算¥362,880見積依頼/購入/質問フォーム
Corporate UserUSD6,720 ⇒換算¥725,760見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

In 2017, the Vaccine Adjuvants market size was xx million USD in United States, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.
In United States market, the top players include
SEPPIC
SDA BIO
Brenntag Biosector
SPI Pharma
MVP Laboratories
Tj Kaiwei
Novavax
Zhuoyue
Aphios
GSK
CSL Limited
Avanti Polar Lipids

Split by product types/category, covering
Oral
Subcutaneous
Intramuscular
Others

Split by applications/end use industries, covers
Adjuvants in each application, can be divided into
Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
Human Vaccine Adjuvants (Research Applications, Commercial Applications)

【レポートの目次】

Table of Contents

2018-2023 United States Vaccine Adjuvants Market Report (Status and Outlook)
1 Vaccine Adjuvants Market Overview
1.1 Product Overview and Scope of Vaccine Adjuvants
1.2 Vaccine Adjuvants Market Segment by Types
1.2.1 United States Vaccine Adjuvants Sales Present Situation and Outlook by Types (2013-2023)
1.2.2 United States Vaccine Adjuvants Sales Market Share by Types in 2017
1.2.3 Oral
1.2.3.1 Major Players of Oral
1.2.4 Subcutaneous
1.2.4.1 Major Players of Subcutaneous
1.2.5 Intramuscular
1.2.5.1 Major Players of Intramuscular
1.2.6 Others
1.2.6.1 Major Players of Others
1.3 United States Vaccine Adjuvants Market Segment by Applications/End Use Industries
1.3.1 United States Vaccine Adjuvants Sales Present Situation and Outlook by Applications/End Industrials (2013-2023)
1.3.2 United States Vaccine Adjuvants Sales Market Share by Applications in 2017
1.3.2 Adjuvants in each application, can be divided into
1.3.3 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
1.3.4 Human Vaccine Adjuvants (Research Applications, Commercial Applications)
1.4 United States Vaccine Adjuvants Overview and Market Size (Value) (2013-2023)
1.4.1 United States Market Vaccine Adjuvants Overview
1.4.2 United States Vaccine Adjuvants Market Size (Value and Volume) Status and Forecast (2013-2023)
2 United States Vaccine Adjuvants Sales, Revenue (Value) and Market Share by Players
2.1 United States Vaccine Adjuvants Sales and Market Share by Players (2013-2018)
2.2 United States Vaccine Adjuvants Revenue and Market Share by Players (2013-2018)
2.3 United States Vaccine Adjuvants Average Price by Players in 2017
2.4 United States Vaccine Adjuvants Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Vaccine Adjuvants Market Competitive Situation and Trends
2.5.1 Vaccine Adjuvants Market Concentration Rate
2.5.2 Vaccine Adjuvants Market Share of Top 3 and Top 5 Players in 2017
2.5.3 Mergers & Acquisitions, Expansion
3 United States Vaccine Adjuvants Sales, Revenue (Value) by Type and Application (2013-2018)
3.1 United States Vaccine Adjuvants Sales, Revenue, Market Share and Price by Type (2013-2018)
3.1.1 United States Vaccine Adjuvants Sales and Market Share by Type (2013-2018)
3.1.2 United States Vaccine Adjuvants Revenue and Market Share by Type (2013-2018)
3.1.3 United States Vaccine Adjuvants Price by Type (2013-2018)
3.2 United States Vaccine Adjuvants Sales and Market Share by Application (2013-2018)
3.3 United States Market Vaccine Adjuvants Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)
4 United States Vaccine Adjuvants Players Profiles and Sales Data
4.1 SEPPIC
4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.1.2 Vaccine Adjuvants Product Types, Application and Specification
4.1.2.1 Type 1
4.1.2.2 Type 2
4.1.3 SEPPIC Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
4.1.4 Main Business/Business Overview
4.1.5 SEPPIC News
4.2 SDA BIO
4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.2.2 Vaccine Adjuvants Product Types, Application and Specification
4.2.2.1 Type 1
4.2.2.2 Type 2
4.2.3 SDA BIO Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
4.2.4 Main Business/Business Overview
4.2.5 SDA BIO News
4.3 Brenntag Biosector
4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.3.2 Vaccine Adjuvants Product Types, Application and Specification
4.3.2.1 Type 1
4.3.2.2 Type 2
4.3.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
4.3.4 Main Business/Business Overview
4.3.5 Brenntag Biosector News
4.4 SPI Pharma
4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.4.2 Vaccine Adjuvants Product Types, Application and Specification
4.4.2.1 Type 1
4.4.2.2 Type 2
4.4.3 SPI Pharma Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
4.4.4 Main Business/Business Overview
4.4.5 SPI Pharma News
4.5 MVP Laboratories
4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.5.2 Vaccine Adjuvants Product Types, Application and Specification
4.5.2.1 Type 1
4.5.2.2 Type 2
4.5.3 MVP Laboratories Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
4.5.4 Main Business/Business Overview
4.5.5 MVP Laboratories News
4.6 Tj Kaiwei
4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.6.2 Vaccine Adjuvants Product Types, Application and Specification
4.6.2.1 Type 1
4.6.2.2 Type 2
4.6.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
4.6.4 Main Business/Business Overview
4.6.5 Tj Kaiwei News
4.7 Novavax
4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.7.2 Vaccine Adjuvants Product Types, Application and Specification
4.7.2.1 Type 1
4.7.2.2 Type 2
4.7.3 Novavax Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
4.7.4 Main Business/Business Overview
4.7.5 Novavax News
4.8 Zhuoyue
4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.8.2 Vaccine Adjuvants Product Types, Application and Specification
4.8.2.1 Type 1
4.8.2.2 Type 2
4.8.3 Zhuoyue Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
4.8.4 Main Business/Business Overview
4.8.5 Zhuoyue News
4.9 Aphios
4.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.9.2 Vaccine Adjuvants Product Types, Application and Specification
9.9.2.1 Type 1
9.9.2.2 Type 2
4.9.3 Aphios Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
4.9.4 Main Business/Business Overview
4.9.5 Aphios News
4.10 GSK
4.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.10.2 Vaccine Adjuvants Product Types, Application and Specification
4.10.2.1 Type 1
4.10.2.2 Type 2
4.10.3 GSK Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
4.10.4 Main Business/Business Overview
4.10.5 GSK News
4.11 CSL Limited
4.11.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.11.2 Vaccine Adjuvants Product Types, Application and Specification
4.11.2.1 Type 1
4.11.2.2 Type 2
4.11.3 CSL Limited Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
4.11.4 Main Business/Business Overview
4.11.5 CSL Limited News
4.12 Avanti Polar Lipids
4.12.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.12.2 Vaccine Adjuvants Product Types, Application and Specification
4.12.2.1 Type 1
4.12.2.2 Type 2
4.12.3 Avanti Polar Lipids Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
4.12.4 Main Business/Business Overview
4.12.5 Avanti Polar Lipids News
5 United States Vaccine Adjuvants Market Forecast (2018-2023)
5.1 United States Vaccine Adjuvants Sales, Revenue and Price Forecast (2018-2023)
5.1.1 United States Vaccine Adjuvants Sales and Growth Rate Forecast (2018-2023)
5.1.2 United States Vaccine Adjuvants Revenue and Growth Rate Forecast (2018-2023)
5.1.3 United States Vaccine Adjuvants Price Trend Forecast (2018-2023)
5.2 United States Vaccine Adjuvants Sales Forecast by Type (2018-2023)
5.3 United States Vaccine Adjuvants Sales Forecast by Application (2018-2023)
6 Production Cost Analysis of Vaccine Adjuvants
6.1 Main Raw Materials of Vaccine Adjuvants
6.1.1 List of Vaccine Adjuvants Main Raw Materials
6.1.2 Vaccine Adjuvants Main Raw Materials Price Analysis
6.1.3 Vaccine Adjuvants Raw Materials Major Suppliers
6.1.4 Vaccine Adjuvants Main Raw Materials Market Concentration Rate
6.2 Production Cost Structure of Vaccine Adjuvants
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Production Expenses
6.3 Vaccine Adjuvants Manufacturing Process/Method
7 Value Chain, Purchasing Strategy and Downstream Buyers
7.1 Vaccine Adjuvants Value Chain Analysis
7.2 Upstream Raw Materials Purchasing
7.3 Raw Materials Sources of Vaccine Adjuvants Major Players in 2017
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Sales Channel
8.1.1 Direct Sales
8.1.2 Indirect Sales
8.1.3 Sales Channel Development Trend
8.2 Product Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Vaccine Adjuvants Distributors/Traders List in United States
9 Market Influences Factors Analysis
9.1 Changes from the Related Industries
9.2 Substitutes Threat
9.3 Customer Preference Change
9.4 Economic/Political Environmental Change
9.5 Upstream and Downstream Fluctuation
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Data Source



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ワクチンアジュバントのアメリカ市場2018-2023(2018-2023 United States Vaccine Adjuvants Market Report (Status and Outlook))]についてメールでお問い合わせはこちらでお願いします。